Thin everywhere except your belly? Your genes may be forcing fat storage there.

FTO’s normal job is to regulate appetite signaling in your hypothalamus. When you eat, FTO helps send the satiety signal that tells your brain you’re full and should stop. It’s part of your internal brake pedal for hunger.

The FTO rs9939609 A allele, carried by roughly 45% of people with European ancestry, impairs this satiety signaling by 20-30%, meaning your brain gets a delayed or muted fullness signal. You can eat a large meal and genuinely not feel as satisfied as someone with typical FTO variants. Your appetite-control system is literally less sensitive.

Day-to-day, this means you often eat past the point where you should feel full. You finish a meal and still feel hungry. You reach for seconds or snacks without the internal brake engaging. Over time, this consistent 10-15% overconsumption (which feels normal to you) preferentially accumulates as visceral fat because your body is storing the excess calories in the deep abdomen.

PPARG controls how fat cells expand and whether new fat cells are created. It acts as a metabolic switch that determines whether your body prefers to expand existing fat cells or create new ones, and whether those cells expand more readily in the visceral or subcutaneous compartment.

The PPARG Pro12 allele, present in roughly 25% of the population, programs fat cells for efficient storage and expansion, particularly in the deep abdominal cavity. Your adipocytes are literally more responsive to caloric signals in the visceral space than in subcutaneous tissue. This creates a preferential partitioning toward visceral accumulation.

This means that even at a stable weight, you accumulate visceral fat preferentially because your fat cells are metabolically programmed that way. You can be very lean overall yet carry significant deep abdominal fat. The behavior is hardwired.

ADRB2 encodes the beta-2 adrenergic receptor, which sits on the surface of fat cells and responds to adrenaline and noradrenaline during exercise. When you work out, your sympathetic nervous system releases catecholamines, which bind to ADRB2 and trigger lipolysis (fat cell breakdown). This is how exercise mobilizes stored energy.

The ADRB2 Gln27Glu and Arg16Gly variants, present in roughly 40% of the population, reduce catecholamine sensitivity by 20-40%, meaning your fat cells release less fat in response to the same exercise stimulus. You can do the same workout as someone with typical ADRB2 variants and mobilize significantly less fat.

This creates a frustrating pattern: you exercise consistently, you’re lean everywhere else, but your visceral fat doesn’t shift because it’s not being mobilized as readily during your workouts. The fat cells are still receiving the signal to release fat, but the response is blunted. Visceral fat accumulation persists despite regular exercise.

MC4R encodes a receptor in your hypothalamus that processes melanocortin signaling, which is one of your brain’s core satiety pathways. When this receptor is functioning properly, it receives appetite-suppressing signals and communicates fullness throughout your central nervous system.

MC4R variants, present in roughly 5% of people with severe obesity (though much rarer overall), reduce receptor sensitivity, meaning your brain receives weaker satiety signals even when the appetite-suppressing hormones are present. You’re literally not hearing your body’s fullness message as clearly.

For those who carry MC4R variants, appetite feels like a constant background hum. You feel hungry more often than others eating the same amount. Visceral fat accumulation happens partly because you’re fighting a hunger signal that never fully quiets. The difference in sensation is real, not imaginary.

LEPR encodes the leptin receptor, which sits on cells throughout your brain and body. Leptin is released by fat cells and sends a signal that says “we have enough energy stores, you can stop eating and increase metabolism.” The leptin receptor is the lock; leptin is the key.

LEPR variants, present in roughly 20-30% of the population, reduce receptor sensitivity, meaning your brain requires higher leptin levels to trigger satiety and metabolic increase. You have leptin in your blood, sometimes in normal or even high amounts, but your brain isn’t hearing the signal as clearly.

This creates a cruel paradox: as you accumulate visceral fat, your fat cells produce more leptin trying to send a stronger signal. But your broken LEPR receptor doesn’t respond proportionally, so your brain still thinks it’s in energy deficit and keeps driving hunger and reducing metabolic rate. More visceral fat doesn’t send the stop-eating signal it should.

ACTN3 encodes alpha-actinin-3, a protein that gives fast-twitch muscle fibers their structural integrity and power-generating capacity. People with functional ACTN3 have strong fast-twitch fibers. Those with the X/X genotype, present in roughly 18% of people with European ancestry, lack functional ACTN3 and have primarily slow-twitch fibers.

The ACTN3 X/X genotype shifts muscle composition toward slow-twitch, which is metabolically efficient for endurance but less capable of high-intensity fat mobilization during explosive exercise. Your fast-twitch fibers are weaker, which means you generate less force during sprints or heavy lifting, the exact stimuli that preferentially mobilize visceral fat.

This means your body’s capacity to mobilize deep abdominal fat through high-intensity work is limited by your muscle fiber genetics. You can do low-intensity endurance work fine, but the intense exercise that most effectively shifts visceral fat is harder for you because your fast-twitch fibers are intrinsically weaker.